Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CeraRoot has developed and commercialized a line of metal-free, zirconia-based ceramic dental implants and prosthetic components. Their products have received regulatory approvals in major markets including FDA clearance (USA), CE mark (Europe), Health Canada license, and TGA approval (Australia). Clinical use is established globally with long-term success data supporting their biocompatibility, osseointegration, strength under masticatory forces, and reduced risk of peri-implantitis compared to traditional titanium systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CeraRoot.